A Phase 2a, Randomized, Doubleblind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients with Diarrhea predominant Irritable Bowel Syndrome (IBS-D)

  • STATUS
    Recruiting
Updated on 20 August 2019

Summary

Are you or a loved one suffering from the abdominal (belly) pain and discomfort, abnormal bowel habits, and bloating of Irritable Bowel Syndrome with Diarrhea (IBS-D)?

Right now, clinical research doctors are seeking volunteers for an investigational drug study in your area to learn how it affects people with IBS-D. Qualified study volunteers may receive the following at no cost: 

•               Investigational drug for Irritable Bowel Syndrome with Diarrhea

•               Study-related care from a local doctor

•               Compensation for time and travel

To qualify, you must be 18 to 65 years of age, living with IBS-D for at least 6 months, and have no history of inflammatory or immune-mediated GI disorders including, but not limited to, inflammatory bowel disease (Crohn’s disease, ulcerative colitis, microscopic colitis, and celiac disease). Study doctors will help determine if this study is right for you.

Details
Condition Recurrent Diarrhea
Clinical Study IdentifierTX228459
Last Modified on20 August 2019

Eligibility

Yes No Not Sure

Inclusion Criteria

Living with IBS-D for at least 6 months
Ages 18-65 inclusive
Both Male and Female

Exclusion Criteria

No IBD (Crohn's disease, ulcerative colitis, celiac disease)
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note